Image source: The Motley Fool.
Neurocrine Biosciences, inc (NASDAQ: NBIX)
Q2 2021 Earnings Call
Aug 3, 2021 , 4:30 p.m. ET
Operator
For further details see:
Neurocrine Biosciences, inc (NBIX) Q2 2021 Earnings Call TranscriptImage source: The Motley Fool.
Neurocrine Biosciences, inc (NASDAQ: NBIX)
Q2 2021 Earnings Call
Aug 3, 2021 , 4:30 p.m. ET
Operator
For further details see:
Neurocrine Biosciences, inc (NBIX) Q2 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
Market:
Neurocrine Biosciences Inc. Website:
2024-04-24 15:15:12 ET Wells Fargo analyst issues OVERWEIGHT recommendation for NBIX on April 23, 2024 04:12PM ET. The previous analyst recommendation was Buy. NBIX was trading at $139.345 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community PR Newswire WHAT THE C@H?! provides a platform for the congenital adrenal hyperplasia (CAH) community to find educational information, share...
Neurocrine Biosciences Inc (NASDAQ:NBIX) revealed on Tuesday topline data for its Phase 2 SAVITRI study of NBI-1065845 in adult subjects with maj...